Guardion Health Sciences Stock Price To Earnings To Growth
Guardion Health Sciences fundamentals help investors to digest information that contributes to Guardion Health's financial success or failures. It also enables traders to predict the movement of Guardion Pink Sheet. The fundamental analysis module provides a way to measure Guardion Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Guardion Health pink sheet.
Guardion |
Guardion Health Sciences Company Price To Earnings To Growth Analysis
Guardion Health's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
CompetitionBased on the latest financial disclosure, Guardion Health Sciences has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Personal Care Products sector and about the same as Consumer Staples (which currently averages 0.0) industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
Guardion Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Guardion Health's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Guardion Health could also be used in its relative valuation, which is a method of valuing Guardion Health by comparing valuation metrics of similar companies.Guardion Health is currently under evaluation in price to earnings to growth category among its peers.
Guardion Fundamentals
Return On Equity | -0.5 | |||
Return On Asset | -0.16 | |||
Profit Margin | 0.52 % | |||
Operating Margin | (18.75) % | |||
Current Valuation | (987.33 K) | |||
Shares Outstanding | 1.35 M | |||
Shares Owned By Insiders | 1.30 % | |||
Shares Owned By Institutions | 21.09 % | |||
Number Of Shares Shorted | 22.26 K | |||
Price To Earning | (0.71) X | |||
Price To Book | 0.32 X | |||
Price To Sales | 0.36 X | |||
Revenue | 12.25 M | |||
Gross Profit | 4.52 M | |||
EBITDA | (3.92 M) | |||
Net Income | 158.03 K | |||
Cash And Equivalents | 14.23 M | |||
Cash Per Share | 0.23 X | |||
Total Debt | 3.77 M | |||
Current Ratio | 11.28 X | |||
Book Value Per Share | 10.71 X | |||
Cash Flow From Operations | (4.37 M) | |||
Short Ratio | 0.18 X | |||
Earnings Per Share | (4.11) X | |||
Target Price | 40.0 | |||
Beta | 0.71 | |||
Market Capitalization | 4.39 M | |||
Total Asset | 11.92 M | |||
Retained Earnings | (93.57 M) | |||
Working Capital | 10.57 M | |||
Current Asset | 12.8 M | |||
Current Liabilities | 466.01 K | |||
Annual Yield | 1.75 % | |||
Net Asset | 11.92 M |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in Guardion Pink Sheet
If you are still planning to invest in Guardion Health Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Guardion Health's history and understand the potential risks before investing.
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |